locale flag badge
This clinical trial website is intended for US residents only, however, the study is open for recruitment globally.

Triple-Negative Breast Cancer Clinical Trial:A Potential Treatment Option for You

Triple-negative breast cancer (TNBC) has limited available treatment options, especially for patients who still have cancer in their breast and/or lymph nodes after pre-operative treatment. The TROPION-Breast03 study is looking to improve treatment options for such patients.

Step 1

Find a research site nearby. This study prioritizes patient needs, starting with convenient locations to receive care.

Step 2

Fill out the pre-screener form. Time is precious – patients fill out this brief online form to determine initial eligibility upfront.

Which patients are eligible for this triple-negative breast cancer clinical trial?

The TROPION-Breast03 study is looking for individuals who:

  • Are at least 18 years old
  • Have been diagnosed with Stage 1-3 triple-negative breast cancer
  • Still have cancer cells after treatment to try to shrink their cancer before surgery (neoadjuvant therapy), either in their breast or lymph node(s) under their arm
  • Have had at least 6 cycles of treatment before surgery
  • Have no known BRCA1 or BRCA2 mutation

In addition, patients must meet certain criteria, as determined during the screening process, in order to participate in this triple-negative breast cancer study.

Loading map ...

Frequently Asked Questions

Tropion logo

Privacy Policy